医学
2019年冠状病毒病(COVID-19)
随机对照试验
药品
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
临床试验
2019-20冠状病毒爆发
重症监护医学
药物试验
呼吸系统
不利影响
辅助治疗
内科学
药理学
病理
爆发
疾病
传染病(医学专业)
作者
Xuan Yin,Jin Zhu,Feng Li,Li Huang,Yanmei Hu,Bo-chang Zhu,Zuqing Wang,Xiying Li,Jianping Li,Lixing Lao,Yiqun Mi,Shifen Xu
标识
DOI:10.1016/j.joim.2024.09.002
摘要
The outbreak of coronavirus disease 2019 (COVID-19) infection posed a huge threat and burden to public healthcare in late 2022. Non-drug measures of traditional Chinese medicine (TCM), such as acupuncture, cupping and moxibustion, are commonly used as adjuncts in China to help in severe cases, but their effects remain unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI